New position paper: “Recommendations for improving the medicinal product pricing process”

The Draft proposal of the Legislative activity plan of the Ministry of Health of the Republic of Croatia for 2018 foresees amendments to the Medicinal Products Act in order to establish a new medicinal product pricing system pursuant to which the Agency for Medicinal Products and Medical Devices, HALMED, would establish the highest permitted price of a medicinal product at which a marketing authorization holder could sell the medicinal product on the Croatian market.

In this position paper AmCham provides recommendations for improving the current medicinal product pricing process.

Adopting AmCham’s recommendations would enable better harmonization of procedures implemented at national level in Croatia with the legal framework of the European Union and practices of other Member States, and it would be an important step towards improved efficiency of the pricing system.